ERBB2 and breast carcinoma: IL21R, IFI30, PI15, and FAM189A2 may be involved in recurrence of Her2-subtype breast cancer IFI30, PI15, FAM189A2, and MYZAP can be used as the specific prognostic markers for Her2-subtype breast cancer.